Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > Back to our regularly scheduled program

<< Previous

Bullboard Posts

Next >>

Comment by BlueJays9293on Jan 06, 2024 6:33pm

136 Views

Post# 35814112

RE:RE:RE:RE:RE:RE:Back to our regularly scheduled program

The next pause is in the low to mid sixties.

You guys can argue about the minutiae all you want but when a major analysis about the results is due imminently, excitement always ensues.

That's been a truism about biotechs for decades.

Invest it or trade it how ever you want, but excitement will always predicate a major look at the numbers.

<< Previous

Bullboard Posts

Next >>

Visionstate set to leverage success in the U.S. market